Molecular diagnostic technology refers to use DNA and RNA as diagnostic materials to detect the existence of defects or abnormal expression of genes by molecular biology technology to make a diagnosis.
Clongene has developed Molecular diagnostic reagents including infectious diseases, inflammation, tumor markers, etc
For the qualitative detection of nucleic acids from the SARS-CoV-2 in nasal swab, nasopharyngeal swab, oropharyngeal swab, bronchoalveolar lavage and sputum specimens.
For the simultaneous qualitative detection and differentiation of SARS-CoV-2, Influenza A and Influenza B virus RNA in nasal swab, nasopharyngeal swab, oropharyngeal swab, bronchoalveolar lavage or sputum.
For the simultaneous qualitative detection and differentiation of Influenza A virus, Influenza B virus and respiratory syncytial virus (RSV) RNA in nasal swab, nasopharyngeal swab, oropharyngeal swab, bronchoalveolar lavage or sputum.
